SCHEMBL28663020

SCHEMBL28663020

CC1(C)c2cc(NC(=O)C3CC4CCCC[C@@H]4N3)ccc2-c2ccc(-c3ccc4[nH]c(C5CCCN5)nc4c3)cc21

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 2/20 0.34
▸ SCN10A Q9Y5Y9 1/20 0.34
▸ DHODH Q02127 2/20 0.34
▸ ULK1 O75385 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ IKBKB O14920 1/20 0.32
▸ CHUK O15111 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ CTSC P53634 4/20 0.32
▸ AAK1 Q2M2I8 1/20 0.32
▸ SCN3A Q9NY46 3/20 0.31
▸ SCN9A Q15858 2/20 0.31
▸ PARP1 P09874 2/20 0.31
▸ SCN5A Q14524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28663018 1.00 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL18849672 1.00 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL18849829 0.93 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL28641205 0.93 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL18849645 0.93 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL28641202 0.93 PSMB8 (0.34) PSMB8SCN10ADHODHULK1CYP2D6
SCHEMBL18849636 0.93 MAOA (0.35) CYP2D6CYP2C9MAOAMAOBCTSC
SCHEMBL18849736 0.89 PSMB8 (0.44) PSMB8SCN10ADHODHULK1IKBKB
SCHEMBL28638185 0.89 PSMB8 (0.44) PSMB8SCN10ADHODHULK1IKBKB
SCHEMBL18849853 0.85 PSMB8 (0.35) PSMB8SCN10ADHODHULK1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349945-B HCV inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2021-10-29 — — CN disclosed
Send feedback